Serial integrated (18)F-fluorodeoxythymidine PET/CT monitoring neoadjuvant chemotherapeutic response in invasive ductal carcinoma

Breast J. 2007 Jul-Aug;13(4):424-5. doi: 10.1111/j.1524-4741.2007.00454.x.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibiotics, Antineoplastic / adverse effects
  • Antimetabolites, Antineoplastic / administration & dosage
  • Antineoplastic Agents, Alkylating / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology*
  • Carcinoma, Ductal, Breast / diagnosis
  • Carcinoma, Ductal, Breast / drug therapy*
  • Carcinoma, Ductal, Breast / pathology*
  • Cyclophosphamide / adverse effects
  • Dideoxynucleosides*
  • Drug Monitoring / methods*
  • Epirubicin / administration & dosage
  • Female
  • Fluorine Radioisotopes
  • Fluorouracil / administration & dosage
  • Humans
  • Middle Aged
  • Neoadjuvant Therapy*
  • Neoplasm Invasiveness
  • Positron-Emission Tomography*
  • Tomography, X-Ray Computed*

Substances

  • Antibiotics, Antineoplastic
  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents, Alkylating
  • Dideoxynucleosides
  • Fluorine Radioisotopes
  • Epirubicin
  • Cyclophosphamide
  • alovudine
  • Fluorouracil